We provide access to highly trained and dedicated staff with expertise in all aspects of cellular therapy and cGMP phase I/II clinical trials. In addition to technical experience we have extensive QA/QC knowledge to secure FDA compliance during the development of each cellular product.For more information, contact Tara Duke, MLS (ASCP)cm, QA Director, at firstname.lastname@example.org or 843-792-6468.
Meet Our Directors
Satish Nadig, M.D., Ph.D., Medical Director: Research interests include regulatory T cell biology and novel innovations in transplantation tolerance including cellular therapy as applied to the inhibition of acute and chronic rejection. Additional interests include humanized animal models for use as pre-clinical in vivo assays.
William Lancaster, M.D. Associate Medical Director of The Center for Cellular Therapy
Shikhar Mehrotra , Ph.D., Co-Scientific Director Oncology and Immunotherapy Programs: Research interests include T cell biology, Activation Induced Cell Death of a T cell (AICD), T cell development in immunity and tolerance, identification of high affinity TCR for prostate cancer, role of cytokines in T cell persistence.
Hongjun Wang, Ph.D., Co-Scientific Director Islet Processing and Stem Cell Therapy Programs: The Wang Laboratory focuses on pancreatic islet cell biology and transplantation immunology in the treatment of type 1 and type 2 diabetes and chronic pancreatitis.